NEWS

Bioscibex secures CHF 100,000 Venture Kick phase III award !

Bioscibex, the biotech hardware startup newly established at BioArk in Monthey, has won the final stage of the Venture Kick program, receiving CHF 100,000 to accelerate the development of its next-generation single-use bioreactors. This follows the company’s entry earlier this month into the Top 100 Swiss Startups ranking at 81st place. Recognition of a promising […]

Bioscibex secures CHF 100,000 Venture Kick phase III award ! Read More »

Start-up Bioscibex has set up at BioArk in Monthey

Start-up Bioscibex, which grew out of an EPFL research laboratory, is on a mission to transform the manufacture of biological medicines. Currently, the commercial-scale cell culture process involves seven complex, costly and contamination-prone steps. However, with its innovative bioreactor, Bioscibex reduces these steps to two, thereby minimising costs, contamination risks and errors. In development for almost a year, the technology aims to help the pharmaceutical industry move towards safer and more efficient production. The start-up has just moved into the BioArk site in Monthey, where it will benefit from a dynamic ecosystem to support its development.

Start-up Bioscibex has set up at BioArk in Monthey Read More »

Precise Health: AI-driven phage therapy platform awarded at International Conference

Precise Health SA, a dynamic start-up from the Energypolis Campus in Sion and supported by The Ark Foundation, has received the Best Innovation Award at the recent Targeting Phage Therapy Congress in Berlin. This distinction underlines the company’s leadership in developing digital solutions for combating multidrug-resistant bacterial infections, a critical challenge in global healthcare.

Precise Health: AI-driven phage therapy platform awarded at International Conference Read More »

Novochizol: Indo-Swiss agricultural partnership with the AgrINovo project

The Valais start-up Novochizol, based at BioArk in Monthey, is innovating in the field of agricultural biotechnology. It is developing a technology based on chitosan nano-sponges aimed at reducing the impact of pesticides. Through the AgrINovo project, Novochizol is collaborating with India to adapt and produce these solutions on a large scale, thereby contributing to more sustainable and environmentally friendly agriculture.

Novochizol: Indo-Swiss agricultural partnership with the AgrINovo project Read More »

Ninsun Biotech: a Valais innovation in the fight against cancer

Based at the BioArk Monthey technology park and supported by the Ark incubator, Ninsun Biotech is developing a platform for detecting cancer stem cells (CSCs) based on glycan pattern recognition. This technology, clinically validated in lung and colorectal cancers, aims to optimize patient stratification, therapeutic monitoring, and accelerate the development of new molecules in oncology.

Ninsun Biotech: a Valais innovation in the fight against cancer Read More »

Start typing and press enter to search

Scroll to Top